Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $920.0 million.

  • Haemonetics' Non-Current Debt fell 2457.65% to $920.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $920.0 million, marking a year-over-year decrease of 2457.65%. This contributed to the annual value of $921.2 million for FY2025, which is 1550.55% up from last year.
  • According to the latest figures from Q4 2025, Haemonetics' Non-Current Debt is $920.0 million, which was down 2457.65% from $920.4 million recorded in Q3 2025.
  • Over the past 5 years, Haemonetics' Non-Current Debt peaked at $1.2 billion during Q4 2024, and registered a low of $559.4 million during Q2 2022.
  • Moreover, its 5-year median value for Non-Current Debt was $765.2 million (2021), whereas its average is $843.8 million.
  • As far as peak fluctuations go, Haemonetics' Non-Current Debt soared by 15845.84% in 2021, and later tumbled by 2457.65% in 2025.
  • Quarter analysis of 5 years shows Haemonetics' Non-Current Debt stood at $698.0 million in 2021, then grew by 8.42% to $756.8 million in 2022, then grew by 13.22% to $856.8 million in 2023, then soared by 42.35% to $1.2 billion in 2024, then dropped by 24.58% to $920.0 million in 2025.
  • Its Non-Current Debt was $920.0 million in Q4 2025, compared to $920.4 million in Q3 2025 and $920.8 million in Q2 2025.